Dalia Perelman

Dalia Perelman

Auto-generated profile, based on publicly available information

Dalia Perelman

Department of Genetics, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
CGChristopher Gardner
Christopher Gardner
Matthew J LandryMatthew J Landry
Matthew J Landry
DPDalia Perelman
Dalia Perelman
CPChristina Petlura
Christina Petlura
LDLindsay R Durand
Lindsay R Durand
SKSun H Kim
Sun H Kim
Consensus has not been reached on what constitutes an optimal diet in individuals with prediabetes and type 2 diabetes mellitus (T2DM), especially between low-carbohydrate options. We compared 2 low-carbohydrate diets with 3 key similarities (incorporating nonstarchy vegetables and avoiding added sugars and refined grains) and 3 key differences (incorporating compared with avoiding legumes, fruits, and whole, intact grains) for their effects on glucose control and cardiometabolic risk factors in individuals with prediabetes and T2DM. Keto-Med was a randomized, crossover, interventional trial. Forty participants aged ≥18 years with prediabetes or T2DM followed the well-formulated ketogenic diet (WFKD) and the Mediterranean-plus diet (Med-Plus) for 12 weeks each, in random order. The diets shared the 3 key similarities noted above. The Med-Plus incorporated legumes, fruits, and whole, intact grains, while the WFKD avoided them. The primary outcome was the percentage change in glycated hemoglobin (HbA1c) after 12 weeks on each diet. Secondary and exploratory outcomes included percentage changes in body weight, fasting insulin, glucose, and blood lipids; average glucose from continuous glucose monitor (CGM), and nutrient intake. The primary analysis was of 33 participants with complete data. The HbA1c values did not differ between diets at 12 weeks. Triglycerides decreased more for the WFKD [percentage changes, −16% (SEM, 4%) compared with −5% (SEM, 6%) for the Med-Plus; P = 0.02] and LDL cholesterol was higher for the WFKD [percentage changes, +10% (SEM, 4%) compared with −5% (SEM, 5%) for the Med-Plus; P = 0.01]. Weight decreased 8% (SEM, 1%) compared with 7% (SEM, 1%) and HDL cholesterol increased 11% (SEM, 2%) compared with 7% (SEM, 3%) for the WFKD compared with the Med-Plus, respectively; however, there was a significant interaction of diet × order for both. Participants had lower intakes of fiber and 3 nutrients on the WFKD compared with the Med-Plus. Twelve-week follow-up data suggest the Med-Plus is more sustainable. HbA1c values were not different between diet phases after 12 weeks, but improved from baseline on both diets, likely due to several shared dietary aspects. The WFKD led to a greater decrease in triglycerides, but also had potential untoward risks from elevated LDL cholesterol and lower nutrient intakes from avoiding legumes, fruits, and whole, intact grains, as well as being less sustainable. This trial was registered at clinicaltrials.gov as NCT03810378.

23 December 2024 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
DPDalia Perelman
Dalia Perelman
HPHeyjun Park
Heyjun Park
YWYue Wu
Yue Wu
AJAlokkumar Jha
Alokkumar Jha
MSMichael P Snyder
Michael P Snyder
The classification of type 2 diabetes and prediabetes does not consider heterogeneity in the pathophysiology of glucose dysregulation. Here we show that prediabetes is characterized by metabolic heterogeneity, and that metabolic subphenotypes can be predicted by the shape of the glucose curve measured via a continuous glucose monitor (CGM) during standardized oral glucose-tolerance tests (OGTTs) performed in at-home settings. Gold-standard metabolic tests in 32 individuals with early glucose dysregulation revealed dominant or co-dominant subphenotypes (muscle or hepatic insulin-resistance phenotypes in 34% of the individuals, and β-cell-dysfunction or impaired-incretin-action phenotypes in 40% of them). Machine-learning models trained with glucose time series from OGTTs from the 32 individuals predicted the subphenotypes with areas under the curve (AUCs) of 95% for muscle insulin resistance, 89% for β-cell deficiency and 88% for impaired incretin action. With CGM-generated glucose curves obtained during at-home OGTTs, the models predicted the muscle-insulin-resistance and β-cell-deficiency subphenotypes of 29 individuals with AUCs of 88% and 84%, respectively. At-home identification of metabolic subphenotypes via a CGM may aid the risk stratification of individuals with early glucose dysregulation.

4 June 2025 in Nature Medicine
Verified
Journal Article
Open access
PDF file
YWyue wu
yue wu
BEBen Ehlert
Ben Ehlert
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
DPDalia Perelman
Dalia Perelman
HPHeyjun Park
Heyjun Park
MSMichael P Snyder
Michael P Snyder
Elevated postprandial glycemic responses (PPGRs) are associated with type 2 diabetes and cardiovascular disease. PPGRs to the same foods have been shown to vary between individuals, but systematic characterization of the underlying physiologic and molecular basis is lacking. We measured PPGRs using continuous glucose monitoring in 55 well-phenotyped participants challenged with seven different standard carbohydrate meals administered in replicate. We also examined whether preloading a rice meal with fiber, protein or fat (‘mitigators’) altered PPGRs. We performed gold-standard metabolic tests and multi-omics profiling to examine the physiologic and molecular basis for interindividual PPGR differences. Overall, rice was the most glucose-elevating carbohydrate meal, but there was considerable interindividual variability. Individuals with the highest PPGR to potatoes (potato-spikers) were more insulin resistant and had lower beta cell function, whereas grape-spikers were more insulin sensitive. Rice-spikers were more likely to be Asian individuals, and bread-spikers had higher blood pressure. Mitigators were less effective in reducing PPGRs in insulin-resistant as compared to insulin-sensitive participants. Multi-omics signatures of PPGR and metabolic phenotypes were discovered, including insulin-resistance-associated triglycerides, hypertension-associated metabolites and PPGR-associated microbiome pathways. These results demonstrate interindividual variability in PPGRs to carbohydrate meals and mitigators and their association with metabolic and molecular profiles.

11 June 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
HPHeyjun Park
Heyjun Park
Ahmed MetwallyAhmed Metwally
Ahmed Metwally
ADAlireza Delfarah
Alireza Delfarah
YWYue Wu
Yue Wu
DPDalia Perelman
Dalia Perelman
MSMichael P Snyder
Michael P Snyder
Distinct metabolic susceptibilities (beta-cell dysfunction, insulin resistance (IR), and impaired incretin response) underlie type 2 diabetes (T2D). However, their relationships with habitual lifestyle behaviors are underexplored. This study integrated high-resolution lifestyle data from wearable devices, continuous glucose monitoring, and smartphone-based food logs with gold-standard physiological tests in 36 individuals at risk for T2D (ClinicalTrials.Gov; NCT03919877; 2019-04-18). Over 6400 timestamped records of diet, sleep, and physical activity were analyzed with in participants with measures of beta-cell function, tissue-specific IR (muscle, hepatic, adipose), and incretin response. We found that lifestyle timing and variability were strongly associated with metabolic subphenotypes: (1) eating timing was associated with muscle IR and incretin function; (2) irregular sleep correlated to IR and incretin function; and (3) Time-of-day effects of physical activity varied by subphenotype. These findings were validated in an independent cohort. Our results highlight novel physiological links between daily behaviors and metabolic risk, informing potential lifestyle modifications for T2D prevention.

13 January 2026 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CKC. Kulkarni
C. Kulkarni
TFT. Fardeen
T. Fardeen
JGJohn Gubatan
John Gubatan
JYJ. Ye
J. Ye
KJK. Jarr
K. Jarr
SSSidhartha Sinha
Sidhartha Sinha

10 August 2021 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
NCNicholas Cauwenberghs
Nicholas Cauwenberghs
MPMary Prunicki
Mary Prunicki
FSFrantišek Sabovčik
František Sabovčik
DPDalia Perelman
Dalia Perelman
KCKévin Contrepois
Kévin Contrepois
CGChristopher Gardner
Christopher Gardner
Angiotensin-converting enzyme 2 (ACE2) serves protective functions in metabolic, cardiovascular, renal, and pulmonary diseases and is linked to COVID-19 pathology. The correlates of temporal changes in soluble ACE2 (sACE2) remain understudied. We explored the associations of sACE2 with metabolic health and proteome dynamics during a weight loss diet intervention. We analyzed 457 healthy individuals (mean ± SD age: 39.8 ± 6.6 y) with BMI 28–40 kg/m2 in the DIETFITS (Diet Intervention Examining the Factors Interacting with Treatment Success) study. Biochemical markers of metabolic health and 236 proteins were measured by Olink CVDII, CVDIII, and Inflammation I arrays at baseline and at 6 mo during the dietary intervention. We determined clinical and routine biochemical correlates of the diet-induced change in sACE2 (ΔsACE2) using stepwise linear regression. We combined feature selection models and multivariable-adjusted linear regression to identify protein dynamics associated with ΔsACE2. sACE2 decreased on average at 6 mo during the diet intervention. Stronger decline in sACE2 during the diet intervention was independently associated with female sex, lower HOMA-IR and LDL cholesterol at baseline, and a stronger decline in HOMA-IR, triglycerides, HDL cholesterol, and fat mass. Participants with decreasing HOMA-IR (OR: 1.97; 95% CI: 1.28, 3.03) and triglycerides (OR: 2.71; 95% CI: 1.72, 4.26) had significantly higher odds for a decrease in sACE2 during the diet intervention than those without (P ≤ 0.0073). Feature selection models linked ΔsACE2 to changes in α-1-microglobulin/bikunin precursor, E-selectin, hydroxyacid oxidase 1, kidney injury molecule 1, tyrosine-protein kinase Mer, placental growth factor, thrombomodulin, and TNF receptor superfamily member 10B. ΔsACE2 remained associated with these protein changes in multivariable-adjusted linear regression. Decrease in sACE2 during a weight loss diet intervention was associated with improvements in metabolic health, fat mass, and markers of angiotensin peptide metabolism, hepatic and vascular injury, renal function, chronic inflammation, and oxidative stress. Our findings may improve the risk stratification, prevention, and management of cardiometabolic complications. This trial was registered at clinicaltrials.gov as NCT01826591.